Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06505226 · ClinicalTrials.gov registry record · NA

Music Mindfulness Study 2a.

A NA study of COVID-19 and Mental Health Issue, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
2
Study locations

NCT06505226: Recruiting NA study of COVID-19 and Mental Health Issue, sponsored by Yale University.

NCT06505226 is a NA study of COVID-19 and Mental Health Issue that is actively recruiting participants, run by Yale University. The registered enrollment target is 70 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06505226, a NA study of COVID-19 and Mental Health Issue, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
2
Study locations

Study Summary

Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or community based. Music has been shown to alleviate multiple symptoms of stress and has been shown to be a preferred and effective support for meditation and mindfulness. However, its role in stress management in PADs engaged in meditation or mindfulness is seldom studied. This study aims to evaluate the effects of a virtual, community-based music mindfulness program on stress management in PAD community members with anxiety and depression during COVID19. Music Mindfulness Study: Investigators will compare the effects of music-backed guided mindfulness mediation and guided mediation alone in alleviating anxiety and depression.

Primary Outcome

The Perceived Stress Scale (PSS-10) is a 10-item, validated, self-report, questionnaire used to assess perceived control and confidence in managing stressful situations over the past month. Scores range from 0 to 40, with higher scores indicated higher levels of perceived stress.

Interventions

  • BEHAVIORAL in person meditation
  • BEHAVIORAL in person meditation using headphones
  • BEHAVIORAL virtual meditation

Study Locations (2)

Connecticut

  • BLOOM - New Haven
  • Musical Intervention Studios - New Haven

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-08-01
Est. Completion 2026-03
Phase NA
Yale University

1,492 total trials

What NCT06505226 shows while recruiting

NCT06505226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which in person meditation is the first listed.

NCT06505226 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT06505226 about?

NCT06505226 is a clinical study titled "Music Mindfulness Study 2a.". Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multipl...

What is the current status of trial NCT06505226?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-08-01. Estimated completion is 2026-03.

What conditions does trial NCT06505226 study?

This clinical trial studies the following conditions: COVID-19, Mental Health Issue.

What interventions are being tested in trial NCT06505226?

The interventions under investigation include: in person meditation (BEHAVIORAL), in person meditation using headphones (BEHAVIORAL), virtual meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06505226?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06505226 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06505226's enrollment target sits among peer trials

70 228th of 298 higher than 69 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06505226, the US trial registry maintained by the National Library of Medicine. NCT06505226 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.